ArticleHuman vaccines & immunotherapeutics2023

Immunogenicity and safety of single booster dose of KD-414 inactivated COVID-19 vaccine in adults: An open-label, single-center, non-randomized, controlled study in Japan.

Junko Terada-Hirashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.